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NEUTROPHIL ADHESION 
BLOCKADE WITH NPC 15669 
DECREASES PULMONARY 
INJURY AFTER TOTAL 
CARDIOPULMONARY 
BYPASS 
Background: Total cardiopulmonary b pass, in an ovine model, is associ- 
ated with increased pulmonary thromboxane A2 production, cellular se- 
questration of white ceils and platelets, transient pulmonary hypertention, 
and increased lung lymph flow and lymph protein clearance when com- 
pared with respective findings with partial cardiopulmonary b pass. This 
study evaluates the effect of neutrophi! adhesion blockade on lung injury 
after cardiopulmonary b pass. Methods: Two groups of anesthetized sheep 
were placed on total cardiopulmonary b pass without assisted ventilation. 
One group of seven sheep was treated before and during total cardiopul- 
monary bypass with the neutrophil adhesion blocker NPC 15669. A second 
group of seven sheep did not receive NPC 15669 treatment before total 
cardiopulmonary b pass. A third group of seven sheep was treated with 
NPC 15669 before initiation of partial cardiopulmonary bypass with 
continued assisted ventilation. Aortic occlusion and hypothermia were not 
used. After 90 minutes all sheep were separated from cardiopulmonary 
bypass, with resumption of assisted ventilation and pulmonary arterial 
fl0w. After 30 minutes the left atrial pressure was elevated mechanically. 
Hemodynamics , thromboxane A 2 levels, plate!et levels, and white blood cell 
and plasma protein concentrations were measured before cardiopulmonary 
bypass and afterwards at  four 15-minute intervals. Samples were taken 
from the right and left atria simultaneously. Lung lymph protein levels and 
flow were measured before and after cardiopulmonary bypass at two 
30-minute intervals. Results: In the total cardiopulmonary b pass group not 
treated with NPC 15669 signs of lung injury developed after cardiopulmo- 
nary bypass. Animals treated with NPC 15669 did not manifest a similar 
degree of lung injury after either partial or total cardiopulmonary b pass. 
Increased pufinonary vascular esistance did not develop in treated sheep 
nor did sequestration of platelets or white blood cells occur. Despite the 
drug, increased pulmonary capillary permeability after total cardiopulmo- 
nary bypass persisted, but was reduced. Conclusions: Compared with 
unmodified total cardiopulmonary b pass, blockade of neutrophil adhesion 
with NPC 15669 reduces, but does not entirely eliminate, lung derangement 
after total cardiopulmonary bypass. (J THORAC CARDIOVASC SURG 1996; 
111:460-8) 
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E xperimental models have established that lung injury occurs after total cardiopulmonary b pass 
(t-CPB)J '2 In a sheep model from our laboratory 
the pulmonary derangement includes an increase in 
left atrial (LA) plasma thromboxane l vel, pulmo- 
nary sequestration of white blood cells (WBCs) and 
platelets, transient pulmonary hypertension, and 
increased lung lymph flow and protein clearance. In 
contrast, these parameters are not much altered by 
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partial CPB (p-CPB). 1 These specific manifestations 
of lung injury after t-CPB are eliminated or reduced 
by treating sheep with a thromboxane synthetase 
inhibitor before CPB. 3 
The changes een after t-CPB are consistent with 
a reperfusion lung injury. One of the potential 
instigators of post-CPB reperfusion injury is the 
neutrophil, 4 which may act as a mediator of acute 
inflammation. Gillinov and associates 2 reported that 
a variety of different lung injury markers were 
ameliorated by the use of the neutrophil adhesion 
blocker NPC 15669 in a porcine t-CPB model. The 
present study examines the role of neutrophils in 
post-CPB lung injury by comparing sheep subjected 
to t-CPB with and without a neutrophil adhesion 
inhibitor administered before and during CPB. The 
effect of the drug in the absence of conditions 
known to promote lung injury was examined in 
sheep subjected to p-CPB, which has not been 
associated with acute lung injury. 
Methods 
The preparation was identical to that described in our 
previous investigations comparing pulmonary parameters 
after p-CPB and t-CPB. 1' 3 Briefly, Dorset-Rambouillet 
sheep (n = 21) weighing 25 to 31 kg (mean 28.5 kg) were 
anesthetized with intravenous a-chloraiose 80 mg/kg and 
urethane 500 mg/kg. Animals were intubated and the 
lungs mechanically ventilated (Harvard Apparatus, Millis, 
Mass.). Arterial blood gas and pH measurements were 
done during the procedure (pH blood gas analyzer 1306, 
Instruments Lab, Lexington, Mass.) and maintained 
within physiologic limits (pH = 7.35 to 7.45, oxygen 
tension >100 torr and <300 torr, carbon dioxide tension 
>35 torr and <45 torr). Systemic arterial pressure was 
monitored by percutaneous cannulation of the femoral 
artery. 
We used the method described by Koike, Albertine, 
and Staub s to collect the pulmonary lymph drainage. 
Through a right thoracotomy in the fifth intercostal space, 
we cannulated the efferent duct of the caudal mediastinal 
lymph node with a small heparin-coated silicone catheter. 
To eliminate any systemic lymph input to the node, 
through another right thoracotomy in the tenth intercostal 
space, we ligated the tail of this node at the caudal margin 
of the pulmonary ligament and cauterized the diaphragm 
around it. 
A midline sternotomy was then done and after Systemic 
heparinization (400 u/kg) the right atrium (RA) and aorta 
were cannulated. As described by Bernard and col- 
leagues 6 and Mitzner and Sylvester, 7 a 16F silicone-coated 
rubber Foley catheter with a 30 ml inflatable balloon Was 
introduced into the LA to increase the left atrial pressure 
(LAP) after 30 minutes of reperfuSion. This LAP increase 
elevated the hydrostatic pressure in the pulmonary venous 
bed and served to magnify capillary permeability changes. 
An 8F Millar catheter (Houston, Tex.) was inserted into 
the LA for pressure recording. The pulmonary artery 
(PA) was cannulated to monitor the PA pressure, and a 
flowmeter (model  12SB234, Transonic Systems Inc., 
Ithaca, N.Y.) was placed around the PA. 
The extracorporeal circuit consisted of a roller pump 
(Cardiovascular Instrument Corp., Wakefield, Mass.) and 
bubble oxygenator (Bentley Bio-2, Baxter Healthcare 
Corp., Irvine, Calif.). The circuit was primed with Ringer's 
lactate solution (25 ml/kg). 
Animals were cared for in accordance with the guide- 
lines established by the Beth Israel Hospital's Animal 
Care and use Committee and those prepared by the 
Committee on the Care and Use of LaboratorY Animals 
of the Institute of Animal Resources, National Research 
Council (Department of Health and Human Services 
Publication No. 86-23, revised 1985). The Beth Israel 
Hospital animal research facility is fully accredited by the 
American Association for Accreditation of Laboratory 
Animal Care. 
Study groups. The study consisted of three experimen- 
tal groups. Two groups underwent t-CPB: one with NPC 
15669 (N-[9H- { 2,7-dimethylftuorenyl-9-methxy} carbonyl]- 
L-leucine), a neutrophil adhesion inhibitor, and one with- 
out. A third group was subjected to p-CPB with NPC 
15669 treatment. In this model there was no period of 
aortic occlusion or associated myocardial ischemia, and 
hypothermia was not induced. 
T-CPB with NPC 15669 (t-CPB + NPC; n = 7). Before 
t-CPB an intravenous bolus dose of NPC 15669, 10 mg/kg, 
was delivered, followed by an infusion of 6 mg/kg per hour 
until the end of the experiment. T-CPB was established 
and the PA was clamped as ventilation was halted. Arte- 
rial flow was maintained at 80 to 100 ml/kg per minute and 
blood gas analysis was done to assess the adequacy of 
perfusion and gas exchange. Paired serial blood samples 
were taken from RA and LA before CPB. T-CPB contin- 
ued for 90 minutes, at which time the PA occluder was 
removed, ventilation was restarted, and CPB discontin- 
ued. Blood samples were taken just after the ischemic 
period and every 15 minutes until the end of the experi- 
ment. Thirty minutes after cessation of CPB the 30 ml 
Foley catheter balloon was inflated for 30 minutes to 
increase the LAP by 10 to 15 mm Hg. 
T-CPB without NPC 15669 (t-CPB/no NPC; n = 7). 
This group Underwent t-CPB as described in the previous 
section, but did not receive NPC 15669. 
P-CPB with NPC 15669 (p-CPB + NPC; n = 7). In this 
group animals received NPC 15669 according to the 
regimen described for the t-CPB + NPC group. Animals 
were then placed on CPB as previously described, but only 
one third of PA flow was allowed to flow through the 
extracorporeal circuit. The remainder of venous return 
flowed through the PA. The lungs were ventilated nor- 
mally. After 90 minutes CPB was terminated and blood 
samples were taken, and at 30 minutes after CPB the LAP 
was raised as described for the other two groups. 
Sample collection and measurements. Samples were 
collected from both atria after aspiration of 5 ml for dead 
space. Two milliliters of blood was placed in ice-cooled 
siliconized tubes containing 0.1 ml of 0.1 mol/L ethyl- 
enediaminetetraacetic acid and 0.05% (weight/volume) 
aspirin in a ratio of 2:1. Hematocrit concentration was 
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measured with each sample to permit correction for 
hemodilution. 
Thromboxane assay. Tubes that contained blood for 
thromboxane assay were immediately centrifuged at 4 ° C 
for 20 minutes at 2000 g. Plasma was separated and stored 
in polypropylene test tubes at -25 ° C until assayed. All 
thromboxane B 2 assays were done within 5 weeks of 
the experiment. Prior viability studies have shown no 
significant change in thromboxane levels for up to 8 weeks 
with this method of storage. 
Thromboxane B2 is a stable, inactive metabolite of the 
physiologically active but unstable thromboxane A2, 
whose half-life is 30 seconds at 37 ° C in aqueous solution. 8
We measured thromboxane B 2 levels with use of a com- 
petitive binding radioimmunoassay. Anti-thromboxane 
B 2 antibody (rabbit), [125I]thromboxane B 2 tracer, throm- 
boxane B 2 standard, bovine serum albumin phosphate 
buffer, and magnetic goat anti-rabbit immunoglobulin G
antibody were obtained from Advanced Magnetic Inc., 
Cambridge, Mass. Assays were done according to the 
manufacturer's in tructions. All results were expressed as 
picograms per 0.1 ml. 
Lymph collection and measurements. Lung lymph was 
collected three times over a 30-minute period: before 
CPB, after CPB, and after the LAP was raised. The fluid 
was drained into cooled tubes containing ethylenedia- 
minetetraacetic acid and aspirin. We measured the quan- 
tity of the lymph in the tubes, and the protein concentra- 
tion was determined by refractometry. 
Plasma protein. Blood was centrifuged for 3 minutes at 
2000 rpm and the plasma protein concentration was then 
determined with a refractometer (Atago Hand Refrac- 
tometer, NSG Precision Cells Inc., Farmingdale, N.Y.). 
Lymph protein clearance. Lung lymph protein clearance 
was calculated from the lymph flow rate (milliliters per 30 
minutes) and the ratio of the lymph to plasma protein 
concentrations by the following formula: lymph flow × 
[lymph protein]/[plasma protein]. 
PlateIet counts. After the blood was centrifuged, plate- 
lets were counted in the supernatant bya Coulter counter 
(model ZF, Coulter Electronic Inc., Hialeah, Fla.]. 
WBC counts. WBCs from whole blood samples were 
counted by means of phase microscopy. 
Pulmonary vascular esistance. The pulmonary vascular 
resistance was calculated by the following formula: mean 
pulmonary arterial pressure - mean LAP/PA flow × 
1332 = pulmonary vascular esistance in dynes • sec 1 . 
cm 5. 
Water content. The water content of the lung tissue was 
determined by taking small lung biopsy samples (<1 gm) 
and placing them on tissue paper to absorb the blood. 
Samples were then weighed and desiccated for 3 days at 
80 ° C at which time they were again weighed and the 
percentage ofwater in the tissue was calculated as follows: 
Wet weight (in grams)-Dry weight (in grams) 
Wet weight (in grams) 
Biopsies were done before CPB and at the conclusion 
of reperfusion. 
Statistical analysis. Values are expressed as means 
plus or minus the standard error of the mean. Means were 
compared by a two-way analysis of variance. Scheffe's test 
for multiple sample comparisons was used to further 
evaluate the significant differences. Significance was de- 
termined at the p < 0.05 level. 
Results 
The mean RA/LA WBC concentrations are sunl- 
marized in Fig. 1. With reperfusion, after 90 minutes 
of CPB, the t-CPB/no NPC group had a statistically 
significant increase in the RA/LA WBC ratio (from 
1.07 _+ 0.02 to 1.72 _+ 0.05). Neither of the NPC 
15669-treated groups had a significant change in 
the ratio (t-CPB/no NPC versus t-CPB + NPC and 
p-CPB + NPC;p < 0.001). Fifteen minutes later the 
ratio returned nearly to the baseline value in all 
three groups and remained stable between 1.0 and 
1.2 until the end of the experiment. The slightly 
lower value in the p-CPB + NPC group did not 
differ to a statistically significant degree from values 
in the t-CPB groups. 
The mean RA/LA platelet counts are shown in 
Fig. 2. On PA reperfusion, after 90 minutes of 
t-CPB, the mean platelet ratio increased from 
0.99 + 0.03 to 1.31 _+ 0.04 in the animals in the 
t-CPB/no NPC group. In the two groups that re- 
ceived NPC 15669 the ratio remained relatively 
constant near unity (t-CPB/no NPC versus t-CPB + 
NPC and p-CPB + NPC; p < 0.005). Fifteen 
minutes after the termination of CPB the mean ratio 
in the t-CPB/no NPC group returned to 1.03 + 0.03; 
it then paralleled the ratio in the treated groups for 
the remainder of the experiment. 
The pulmonary vascular resistance was un- 
changed after 90 minutes of p-CPB or t-CPB with 
NPC 15669 (Fig. 3). In the t-CPB/no NPC group the 
pulmonary vascular resistance rose from 171 _+ 
34 dynes • sec -1 • cm -1 before CPB to 351 _+ 48 at 
the end of CPB (t-CPB/no NPC versus t-CPB + 
NPC and p-CPB + NPC; p < 0.01). After 15 
minutes the pulmonary vascular esistance f ll in the 
t-CPB/no NPC group to a mean value near that of 
the p-CPB + NPC group, but this value was still 
significantly greater than that in the t-CPB + NPC 
group (p < 0.05). 
Thirty minutes after CPB in the p-CPB + NPC 
group, lymph flow increased compared with the 
pre-CPB baseline flow by 45% _+ 17% (Fig. 4) and 
by 47% _+ 19% after 30 more minutes (with in- 
creased LAP). In the t-CPB + NPC group, the 
lymph flow increased at these times by 131% _+ 27% 
and 200% _+ 41%, respectively. The t-CPB/no NPC 
group showed an increase of 243% _+ 38% in lymph 
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Table I. Percent lung water content 
Increase in 
Experimental group Before CPB After CPB water content 
p-CPB + NPC 15669 80.0 _+ 0.1 83.0_+ 0.1 3.0 _+ 0.1 
t-CPB + NPC 15669 81.0 _+ 0.1 83.4 _+ 0.1 2.4 _+ 0.1 
t-CPB/no NPC 15669 79.9 _+ 0.1 84.9 _+ 0.1 5.0 -+ 0.1" 
*p < 0.05; t-CPB/no NPC 15669 versus t-CPB + NPC 15669. 
flow after 30 minutes and 279% _+ 51% after 30 
more minutes (t-CPB/no NPC versus t-CPB + NPC 
and p-CPB + NPC; p < 0.05). 
The calculated lymph protein clearance from the 
lung increased in all groups 30 and 60 minutes after 
CPB (Fig. 5), but the elevation in the p-CPB + NPC 
group was not significant compared with the mean 
baseline value. The protein clearance in the 
t-CPB/no NPC group increased from 3.20 _+ 1.27 
ml/30 minutes before CPB to 7.83 _+ 1.56 ml/30 
minutes after 30 minutes and to 7.78 _+ 1.30 ml/30 
minutes after 30 more minutes (with elevated LAP). 
These values were significantly higher than the 
mean values for the p-CPB + NPC group. After the 
LA balloon inflation, despite neutrophil adhesion 
inhibition, the t-CPB + NPC group demonstrated 
protein clearance that was significantly greater than 
that seen in the p-CPB group and that was nearly 
equal to the clearance in the untreated group. 
Serum thromboxane concentration from the RA 
and LA are shown in Fig. 6. After 90 minutes of 
either p-CPB or t-CPB with NPC 15669, with the 
initiation of reperfusion, there was a small increase 
in thromboxane concentration i  the RA and in the 
LA (p = not significant). With cessation of CPB in 
the t-CPB/no NPC group there was a similar rise in 
RA thromboxane concentration, but the LA throm- 
boxane concentration i creased more dramatically 
to 636 _+ 196 pg/0.1 ml (t-CPB/no NPC thrombox- 
ane concentration RA versus LA; p < 0.05). Fifteen 
minutes later and until the end of the experiment 
the thromboxane concentrations were near pre-CPB 
levels in all three groups. 
After the total experiment (90 minutes of CPB 
plus 60 minutes of reperfusion; the last 30 minutes 
with LAP elevated) the mean water content of the 
lung tissue increased by 2% _+ 0.1% in the t-CPB + 
NPC group and by 5% + 0.1% in the t-CPB/no NPC 
group (p < 0.05; Table I). The p-CPB + NPC 
increase was an intermediate value of 3.0% _+ 0.1%. 
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Discussion 
Neutrophil function in inflammation requires ac- 
tivation and attachment to the endothelium before 
degranulation or migration. 9 NPC 15669 is an inhib- 
itor to CD11/CD18 upregulation. 1° Neutrophil sur- 
face adherence receptors (CDll/CD18) have an 
important role in the interaction between neutro- 
phils and endothelium. H These neutrophil ntegrins 
are upregulated in response to an inflammatory 
process, promoting endothelial attachment and tis- 
sue migration. The blockade of neutrophil ntegrins 
impairs endothelial attachment and migration. Al- 
though the long-term toxicity of NPC 15669 elimi- 
nates its clinical use, less toxic drugs with a similar 
activity will become clinically available. 
This study demonstrates the ability of the neutro- 
phil adhesion inhibitor NPC 15669 to reduce mark- 
ers of lung injury after t-CPB. Compared with 
findings in control animals, NPC 15669 administra- 
tion before t-CPB eliminated the increase in LA 
thromboxane l vels seen in sheep that were not 
treated. Furthermore, sheep treated with NPC 
15669 before t-CPB had less sequestration f WBCs 
and platelets in the lung and no pulmonary vascular 
resistance increase. Pulmonary capillary permeabil- 
ity after t-CPB and NPC 15669 treatment was 
significantly decreased compared with that in un- 
treated t-CPB animals, but the capillary permeabil- 
ity was not reduced to the levels seen in the p-CPB 
+ NPC group. 
With use of the same model as that used in this 
study we have previously demonstrated a variety of 
pulmonary derangements in sheep subjected to 
t-CPB, but not in those subjected to p-CPB. 1 The 
results from the p-CPB + NPC group in this study 
were 'nearly identical to those seen previously after 
p-CPB alone, 1 which suggests neither benefit nor 
adverse consequences of the drug itself in the ab- 
sence of t-CPB. The amelioration of pulmonary 
injury after t-CPB provided by neutrophil adhesion 
blockade is similar to that provided by thromboxane 
synthase inhibition using dazmegrel) The reduction 
in leukocyte and platelet sequestration and the 
reduction in pulmonary vasoconstriction were 
nearly identical in dazmegrel-treated animals sub- 
jected to t-CPB. As with NPC 15669, dazmegrel was 
not able to totally obviate an increase in capillary 
permeability, but clearly the elevation of LA serum 
thromboxane concentration is associated with lung 
injury after t-CPB. The elimination of a serum 
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thromboxane concentration i crease by NPC 15669, 
similar to the reduction seen in our prior study with 
dazmegret, 3 may be the primary factor in its reduc- 
ing post-CPB lung damage, but neutrophils may pro- 
mote lung injury through a variety of mechanisms 
other than thromboxane r lease or production. 
Neutrophils play an important role in the inflam- 
matory response and in the damage that occurs with 
reperfusion.12, 13 White cell depletion or neutrophil 
adhesion blockade before reperfusion of ischemic 
hearts decreases infarct size. 14' is With leukocyte- 
depleted blood reperfusion Breda and associates 16
reported improved myocardial function after isch- 
emia, and Wilson and colleagues 17reported reduced 
myocyte damage and better ventricular systolic func- 
tion after global myocardial ischemia. 
With respect o post-CPB lung injury, Johnson 
and associates 18 demonstrated that dogs treated 
with either indomethacin or a leukocyte filter before 
p-CPB had better arterial oxygenation after CPB 
than untreated ogs. Bando and associates 19found 
that leukocyte depletion can reduce lung injury after 
t-CPB, and Cave and associates 2°showed that neu- 
trophils play an important role in pulmonary vaso- 
constriction after CPB. Our findings support hose 
of these studies and particularly the work of 
Gillinov and colleagues, 2 who subjected piglets to 
t-CPB with and without NPC 15669. They demon- 
strated a significant reduction in lung injury with the 
drug, manifest by a lack of pulmonary vasoconstric- 
tion, improved arterial oxygenation, absence of neu- 
trophil sequestration, and less lung edema. 
This study does not define the specific stimulus of 
the pulmonary inflammatory state and damage that 
occurs with total, but not partial, CPB. We did not 
use hypothermia, nor was there a period of cardiac 
ischemia. Simultaneously drawn RA and LA throm- 
boxane levels localize at least a part of the inflam- 
matory effect of CPB to the pulmonary circulation. 
The inflammation is consistent with postischemic 
reperfusion, and lung tissue ischemia may occur 
with t-CPB as ventilation and pulmonary arterial 
flow are stopped and only nonpulsatile bronchial 
arterial flow supplies oxygen to the lung tissue. 
This study does confirm the critical role of neu- 
trophils in lung damage after t-CPB. There are, 
however, mechanisms of lung damage other than 
neutrophil activation inasmuch as capillary leak 
after CPB is not totally prevented by NPC 15669. A 
better understanding of the stimulus of pulmonary 
damage after t-CPB is needed to more completely 
prevent his pathophysiologic condition. 
REFERENCES 
1. Friedman M, Sellke FW, Wang SY, Weintraub RM, 
Johnson RG. Parameters of pulmonary injury after 
total or partial cardiopulmonary b pass. Circulation 
1994;90:1200-7. 
2. Gillinov AM, Redmond JM, Zehr KJ, et al. Inhibition 
Of neutrophil adhesion during cardiopulmonary b - 
pass. Ann Thorac Surg 1994;57:126-33. 
3. Friedman M, Wang SY, Sellke FW, Franklin A, 
Weintraub RM, Johnson RG. Comparison of pulmo- 
nary injury after total and partial cardiopulmonary 
bypass with thromboxane synthesis inhibition. Ann 
Thorac Surg 1995;59:598-603. 
4. Goldman G, Welbourn R, Klausner JM, Valeri CR, 
Shepro D, Hechtman HB. Thromboxane mediates 
diapedesis after ischemia by activation of neutrophil 
adhesion receptors interacting with basally expressed 
intercellular adhesion molecule-1. Circ Res 1991;68: 
1013-9. 
5. Koike K, Albertine KH, Staub NC. Intrathoracic 
sources of caudal mediastinal lymph node efferent 
lymph in sheep. J Appl Physiol 1986;60:80-4. 
6. Bernard GR, Snapper JR, Hutchison AA, Brigham 
KL. Effects of left atrial pressure levation and hista- 
mine infusion on lung lymph in awake sheep. J Appl 
Physiol 1984;56:1083-9. 
7. Mitzner W, Sylvester JT. Lymph flow and lung weight 
in isolated sheep lungs. J Appl Physiol 1986;61:1830-5. 
8. Cannon PJ. Eicosanoids and the blood vessel wall. 
Circulation 1984;70:523-8. 
9. Root RK. Leukocyte adhesion proteins: their role in 
neutrophil function. Trans Am Clin Climatol Assoc 
1989;101:207-24. 
10. Bator JM, Weitzberg M, Butch RM. N-(9H-[2,7- 
dimethylfluorenyl-9-methoxy]carbonyl)-L-leucine, NPC 
15669, prevents neutrophil adherence to endothelium 
and inhibits CD11b/CD18 upregulation. Immunophar- 
macology 1992;23:139-49. 
11. Shappel SB, Toman C, Anderson DC, Taylor AA, 
Entman ML, Smith CW. Mac-1 (CDllb/CD18) me- 
diates adherence-dependent hydrogen peroxide pro- 
duction by human and canine neutrophils. J Immunol 
1990;144:2702-11. 
12. Fantone JC, Ward PA. Role of oxygen derived free 
radicals and metabolites in leucocyte-dependent in- 
flammatory reaction. Am J Pathol 1982;107:397-418. 
13. Rossen RD, Swain JL, Michael LH, SeaMy S, Gian- 
nini E, Entman ML. Selective accumulation of the 
first component of complement and leucocytes in 
ischemic canine heart muscle: a possible initiator of 
an extra myocardial mechanism of ischemic injury. 
Circ Res 1985;57:119-30. 
14. Litt MR, Jeremy RW, Weisman HF, Winkelstein JA, 
Becket LC. Neutrophil depletion limited to reperfu- 
sion reduced myocardial infarct size after 90 minutes 
of ischemia. Circulation 1989;80:1816-27. 
15. Curtis WE, Gillinov AM, Wilson IC, et al. Inhibition 
4 6 8 Friedman et al. 
The Journal of Thoracic and 
Cardiovascular Surgery 
February 1996 
of neutrophil adhesion reduces myocardial infarct 
size. Ann Thorac Surg 1993;56:1069-73. 
16. Breda MA, Drinkwater DC, Laks H, et al. Prevention 
of reperfusion injury in the neonatal heart with leu- 
cocyte-depleted blood. J THORAC CARDIOVASC aURa 
1989;97:654-65. 
17. Wilson I, Gillinov AM, Curtis WE, et al. Inhibition of 
neutrophil adherence improves postischemia ventric- 
ular performance of the neonatal heart. Circulation 
1993;88(pt 2):372-9. 
18. Johnson D, Thomson D, Hurst T, et al. Neutrophil- 
19. 
20. 
mediated acute lung injury after extracorporeal 
perfusion. J THORAC CARDIOVASC SURG 1994;107: 
1193-202. 
Bando K, Pillai R, Caneron DE, et al. Leucocyte 
depletion ameliorates free radical-mediated lung in- 
jury after cardiopulmonary b pass. J TuoP, ac CARD~O- 
VASC SURG 1990;99:873-7. 
Cave AC~ Manche A, Derias NW, Hearse DJ. Throm- 
boxane A2 mediates pulmonary hypertention after 
cardiopulmonary b pass in the rabbit. J THOP, AC CAR- 
D]OVASC SURG 1993;106:959-67. 
